Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neprilysin: assay methods, purification, and characterization.

Literature DB >> 7674925

Neprilysin: assay methods, purification, and characterization.

C Li¹, L B Hersh.

Abstract

Entities: Gene

Mesh：

Substances：
Neprilysin

Year: 1995 PMID： 7674925 DOI： 10.1016/0076-6879(95)48018-8

Source DB: PubMed Journal: Methods Enzymol ISSN： 0076-6879 Impact factor: 1.600

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.

Authors: Carrie McAllister; Jiangang Long; Adrienne Bowers; Aaron Walker; Philip Cao; Shin-Ichiro Honda; Nobuhiro Harada; Matthias Staufenbiel; Yong Shen; Rena Li
Journal: J Neurosci Date: 2010-05-26 Impact factor: 6.167

2. Tat peptides inhibit neprilysin.

Authors: Abigail Daily; Avindra Nath; Louis B Hersh
Journal: J Neurovirol Date: 2006-06 Impact factor: 2.643

3. Susceptibility of the cysteine-rich N-terminal and C-terminal ends of rat intestinal mucin muc 2 to proteolytic cleavage.

Authors: I A Khatri; G G Forstner; J F Forstner
Journal: Biochem J Date: 1998-04-01 Impact factor: 3.857

4. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

Authors: S Zini; M C Fournie-Zaluski; E Chauvel; B P Roques; P Corvol; C Llorens-Cortes
Journal: Proc Natl Acad Sci U S A Date: 1996-10-15 Impact factor: 11.205

5. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.

Authors: Rajni Parthasarathy; K Martin Chow; Zahra Derafshi; Michael P Fautsch; John R Hetling; David W Rodgers; Louis B Hersh; David R Pepperberg
Journal: Exp Eye Res Date: 2015-07-02 Impact factor: 3.467

6. Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

Authors: Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller
Journal: Am J Pathol Date: 2009-03 Impact factor: 4.307

Neprilysin: assay methods, purification, and characterization.

1. Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.

2. Tat peptides inhibit neprilysin.

3. Susceptibility of the cysteine-rich N-terminal and C-terminal ends of rat intestinal mucin muc 2 to proteolytic cleavage.

4. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

5. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.

6. Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

7. In vitro and in vivo degradation of Abeta peptide by peptidases coupled to erythrocytes.

8. Neprilysin protects neurons against Abeta peptide toxicity.

Review 9. The wrickkened pathways of FGF23, MEPE and PHEX.

10. Protection against vascular leak in neprilysin transgenic mice with complex overexpression pattern.